Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
Department of Thoracic and Cardiovascular Surgery, Heart, Vascular, and Thoracic Institute, Cleveland Clinic; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.
Cleve Clin J Med. 2022 May 2;89(5):269-279. doi: 10.3949/ccjm.89a.21053.
Esophageal cancer is the sixth most common cause of cancer-related death worldwide. Esophageal adenocarcinoma is the most common subtype of esophageal cancer in the United States, and its incidence has risen dramatically in the last few decades. Modern endoscopic and surgical techniques have significantly improved morbidity and mortality rates of patients undergoing treatment for esophageal cancer. However, most cases are diagnosed at a late stage when the prognosis is poor, emphasizing the need for an effective screening strategy. This clinical overview focuses on screening, multidisciplinary evaluation, and treatment of early esophageal adenocarcinoma.
食管癌是全球第六大常见癌症死亡原因。在美国,食管腺癌是食管癌最常见的亚型,在过去几十年中其发病率急剧上升。现代内镜和外科技术显著改善了接受食管癌治疗的患者的发病率和死亡率。然而,大多数病例在预后较差的晚期诊断,这强调了需要有效的筛查策略。本临床综述重点介绍早期食管腺癌的筛查、多学科评估和治疗。